Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_assertion type Assertion NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_head.
- NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_assertion description "[Secondary outcomes included progression to CDR at least 0�5, symptomatic Alzheimer's disease (score of at least 0�5 for memory and at least one other domain and cognitive impairments deemed to be due to Alzheimer's disease), and mortality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_provenance.
- NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_assertion evidence source_evidence_literature NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_provenance.
- NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_assertion SIO_000772 24012374 NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_provenance.
- NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_assertion wasDerivedFrom befree-2016 NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_provenance.
- NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_assertion wasGeneratedBy ECO_0000203 NP1108289.RAtUoSCO_GSz6GlUcfY7kuUHHi6ruQbXD4HTavSj4g8HU130_provenance.